Evidence map›Paper›PMID 42897158›Full record

ArticleNature communications2026

Uncoupling of the allosteric signalling network in the β

Thomas H Harman, Timothy Noel, Ali Nokhbehzaim, Abigail Pearce, Andrew J Y Jones, Anjana Saji, Matthew Harris, Venkat S Vege, Aneesh Chandran, Pierre Leroy and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Thomas H HarmanDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.
Timothy NoelDepartment of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.
Ali NokhbehzaimDepartment of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.
Abigail PearceDepartment of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.ORCID 0000-0001-9845-0541
Andrew J Y JonesDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.
Anjana SajiDepartment of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.ORCID 0009-0007-0775-690X
Matthew HarrisDepartment of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.
Venkat S VegeDepartment of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.ORCID 0009-0004-1662-0375
Aneesh ChandranDepartment of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK.
Pierre LeroyDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.ORCID 0009-0008-2387-1809
Suleiman Al-SabahDepartment of Pharmacology & Toxicology, Faculty of Medicine, Kuwait University, Kuwait City, 13060, Kuwait.ORCID 0000-0002-9808-7866
Graham LaddsDepartment of Pharmacology, University of Cambridge, Cambridge, CB2 1PD, UK. grl30@cam.ac.uk.ORCID 0000-0001-7320-9612
Daniel NietlispachDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK. dn206@cam.ac.uk.ORCID 0000-0003-4364-9291

Funding

RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/W014831/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/W020718/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/X010899/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/Y513817/1
6 · The paper itself

Abstract

Allosteric modulation is a fundamental aspect of G protein-coupled receptor (GPCR) regulation where molecules that bind to alternative sites outside the orthosteric pocket alter agonist-induced signalling responses. The advantages of allosteric modulators over traditional orthosteric agonists have positioned them as highly promising therapeutic agents. GPCRs exist in tuneable equilibria between multiple functional states, yet the ways in which allosteric modulators reshape these equilibria remain incompletely understood. Here we characterise how changes to the allosteric signalling network influence the conformational dynamics of the β

Indexed as

Receptors, Adrenergic, beta-1Signal TransductionAdrenergic beta-1 Receptor AgonistsAllosteric RegulationAllosteric SiteAnimalsHEK293 CellsHumansMolecular Dynamics SimulationMutationProtein ConformationAdrenergic beta-1 Receptor AgonistsReceptors, Adrenergic, beta-1

Identifiers

PMID42897158
PMCPMC13680373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.